https://biotechmorning.com/news/40-year-drought-aatd-sanofi-wave Biotech Morning en 2026-07-06T14:25:44.277Z The 40-Year Drought That Two Companies Are Racing to End https://biotechmorning.com/news/big-pharma-trump-pricing-deals-tariff-relief Biotech Morning en 2026-07-06T14:24:55.849Z Big Pharma Just Got a Hall Pass (With Strings Attached) https://biotechmorning.com/news/regeneron-parabilis-2-3-billion-helicon-deal Biotech Morning en 2026-07-06T14:24:12.294Z The $2.3B Bet on a Drug That's Not Quite an ADC https://biotechmorning.com/news/roche-divarasib-beats-amgen-bms-kras-lung-cancer Biotech Morning en 2026-07-06T14:23:26.129Z Roche Just Beat Both Rivals in KRAS Lung Cancer. At the Same Time. https://biotechmorning.com/news/immunovant-fcrn-inhibitor-eye-disease-failure Biotech Morning en 2026-07-06T14:22:40.640Z A Lesson About Antibodies and Eyeballs https://biotechmorning.com/news/lilly-engage-biologics-tethosome-non-viral-dna-delivery Biotech Morning en 2026-07-06T14:21:56.741Z Lilly's $202M Bet on a Protein That Sneaks DNA Past Your Immune System https://biotechmorning.com/news/denmark-861m-bet-europes-biotech-capital Biotech Morning en 2026-07-06T14:21:11.943Z Denmark's $861M Bet to Become Europe's Biotech Capital https://biotechmorning.com/news/biomarin-270m-inozyme-phase-3-failure Biotech Morning en 2026-07-06T14:20:37.167Z BioMarin Spent $270M on a Drug That Works in the Blood but Not in the Bones https://biotechmorning.com/news/regeneron-fianlimab-keytruda-melanoma-phase-3-failure Biotech Morning en 2026-07-06T14:19:54.821Z Regeneron Just Got Schooled by the Drug It Was Trying to Beat https://biotechmorning.com/news/biontech-selling-german-manufacturing-sites Biotech Morning en 2026-07-05T14:25:24.263Z BioNTech Built a Vaccine Empire. Now It's Selling Off the Factories. https://biotechmorning.com/news/colorado-enbrel-price-cap-blocked-federal-court Biotech Morning en 2026-07-05T14:24:33.421Z Colorado Tried to Slash Enbrel's Price by 70%. A Judge Said No. https://biotechmorning.com/news/anthropic-claude-science-pharma-launch Biotech Morning en 2026-07-05T14:23:43.157Z Anthropic Just Became a Drug Company (Sort Of) https://biotechmorning.com/news/roche-axelios-sequencer-challenges-illumina Biotech Morning en 2026-07-05T14:22:39.748Z Roche Just Kicked Down Illumina's Front Door https://biotechmorning.com/news/car-t-hunts-tumors-and-bodyguards-gpnmb Biotech Morning en 2026-07-05T14:21:45.185Z The CAR-T That Hunts Tumors and Their Bodyguards https://biotechmorning.com/news/chikungunya-vaccine-ixchiq-us-withdrawal Biotech Morning en 2026-07-05T14:20:51.478Z A Chikungunya Vaccine Just Vanished from the U.S. https://biotechmorning.com/news/sandoz-generic-glp1-fda-review Biotech Morning en 2026-07-05T14:20:02.620Z The World's Biggest Generics Maker Just Came for Ozempic's Crown https://biotechmorning.com/news/zymeworks-acquires-theravance-copd-drug Biotech Morning en 2026-07-05T14:19:14.299Z The Cancer Company That Just Bought a Lung Drug https://biotechmorning.com/news/tepezza-loses-thyroid-eye-disease-monopoly Biotech Morning en 2026-07-05T14:18:21.486Z Tepezza Just Lost Its Monopoly. Here's What Dethroned It.